City
Epaper

New wrist device can 'significantly' reduce tics in Tourette syndrome

By IANS | Updated: March 13, 2023 11:50 IST

London, March 13 A new wrist device has shown to significantly reduce the severity and frequency of tics ...

Open in App

London, March 13 A new wrist device has shown to significantly reduce the severity and frequency of tics among people with Tourette syndrome, according to results of a clinical trial.

In the trial, which included 121 people across the UK, the prototype wrist device Neupulse delivered electrical pulses to reduce the amount and severity of tics experienced by individuals with Tourette's.

Tourette Syndrome (TS) is a neurodevelopmental condition that is usually diagnosed between the ages of eight and 12. It causes involuntary sounds and movements called tics.

Tics are repetitive, stereotyped movements and vocalisations that occur in bouts, typically many times in a single day, and are often preceded by a strong urge-to-tic, referred to as a premonitory urge (PU).

"The Neupulse device has shown the potential to dramatically improve the lives of those with Tourette syndrome, who often face challenges managing their tics, by providing increased control over their tics on demand," said Professor Stephen Jackson from the University of Nottingham, who developed the device along with the spin-out company Neurotherapuetics.

The device was used by trial participants at home at a similar time each day for 15 mins for a period of one month. A subset of people were also videoed each day. Each week participants gave feedback on their experience.

The results, detailed in the preprint site MedRxive and not peer-reviewed, revealed that people who received active stimulation experienced a significant reduction in the severity and frequency of their tics.

On average, they saw a reduction in tic frequency of more than 25 per cent while they received stimulation.

After using the device for four weeks, people who received active stimulation experienced a reduction in their tic severity of more than 35 per cent. In total, 59 per cent of the people who received active stimulation experienced a reduction in tic severity of at least 25 per cent.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: NeurotherapueticsStephen jacksonukLondonUniversity Of NottinghamPremier of saAdministrative capitalIntensive care medicine at university college londonTohoku university graduate school of medicineUniversities of nottinghamCapital cultural hall
Open in App

Related Stories

PuneNilesh Ghaywal, Pune Gangster and Accused in Kothrud Firing Case, Flees to London

BusinessTata Motors Shares Fall After JLR Faces ₹20,000 Crore Cyberattack Erasing FY25 Profits

InternationalDonald Trump Says London Mayor Sadiq Khan Among 'Worst' in World, Claims He Blocked Him from Royal Banquet

EntertainmentAnoushka Shankar and Arijit Singh Team Up for a Special Performance in London, Sitarist Says ‘There’s more to come’

CricketENG vs SA 2nd ODI LIVE Cricket Streaming: When and Where to Watch England vs South Africa Match in India

Health Realted Stories

HealthDelhi HC orders Army to grant disability pension to retired nursing officer

HealthOver 11.31 lakh health camps organised under Swasth Nari, Sashakt Nari Abhiyaan: Govt

HealthHigh carb, saturated fat, low protein intake driving diabetes, obesity in India: ICMR study

HealthBangladesh: Three people die due to dengue, fatalities in 2025 rise to 198

HealthIndian pharma exports expected to cross $30bn this year, rise sharply by 2030: Minister